Agillic A/S - Reporting of transactions in Agillic A/S shares by persons with managerial responsibilities

Udgivet den 10-06-2020  |  kl. 10:45  |  

Announcement no. 12 2020

Copenhagen - 10 June 2020 - Agillic A/S (Nasdaq First North Copenhagen) has received notification pursuant to Article 19 of the Market Abuse Regulation of transactions related to shares in Agillic A/S made by persons with managerial responsibilities in Agillic and/or persons closely associated with them.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Emre Gürsoy Holding ApS
2 Reason for the notification
a) Position/status The company is owned and controlled by managing director Emre Gürsoy
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
a) Name Agillic A/S
b) LEI 894500WP4D8JDZ88S128
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction: (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument
Identification code
Shares
Agilc DK0060955854
b) Nature of the transaction Sale
c) Price(s) and volume(s) Price(s) Volume(S)
DKK 19,20  15.625 shares
d) Aggregated information Aggregated volumePrice  

15.625 shares
DKK 300.000,00
e) Date of the transaction 30-03-2020
f) Place of transaction Nasdaq Copenhagen First North
 



For further information, please contact:
Emre Gürsoy, CEO, Agillic A/S
+45 30 78 42 00
emre.gursoy@agillic.com

Christian Tange, CFO, Agillic A/S
+45 29 48 84 17
christian.tange@agillic.com


Certified Adviser 
Tofte & Company
Sasja Dalgaard sd@toftecompany.com
Christian IX's Gade 7, 1111 Copenhagen K 


About Agillic A/S
Agillic is a Nordic software company enabling marketers to maximise the use of data and translate it into relevant and personalised communication establishing strong relations between people and brands. Our customer marketing platform uses AI to enhance the business value of customer communication. By combining data-driven customer insights with the ability to execute personalised communication, we provide our clients with a head start in the battle of winning markets and customers.

Besides the company headquarter in Copenhagen, Agillic has sales offices in London (UK) and Stockholm (Sweden), Zurich (CH), as well as a development unit in Kiev (Ukraine). For further information, please visit www.agillic.com

Agillic A/S (publ) (Nasdaq First North Copenhagen: AGILC) is obligated to publish the above information in compliance with the EU Market Abuse Regulation. The information was published via agent by Agillic A/S on 10 June 2020.

Attachment

Agillic Company Announcement 12 2020

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed
10:19 FLSmidth foreslår Mads Nipper som ny bestyrelsesformand
09:18 Zealand Pharma bankes i bund på børsen efter FDA-afvisning - aktionærer taber 5,3 mia. kr.
09:14 Aktier/åbning: Zealand Pharma falder tungt efter FDA-afvisning i rødt C25
09:11 Zealand Pharma bankes i bund på børsen efter FDA-afvisning
08:52 Obligationer/åbning: Små renteudsving før inflationsnyt fra USA
08:23 DNB sænker sin værdiansættelse af Zealand Pharmas Glepaglutid efter FDA-afvisning
08:13 Vigtigt rateindeks for Mærsk stiger for fjerde uge i træk
08:12 Væksten i dansk økonomi i tredje kvartal nedrevideret
08:09 Råvarer: Oliepriserne falder på styrket dollar og stagnerende kinesisk efterspørgsel
08:04 Vigtigt rateindeks for Mærsk stiger for fjerde uge i træk
07:59 Zealand Pharmas aktiekurs kan blive trykket af nye datakrav spår Nordnet
07:50 Aktier/tendens: Zealand Pharma i fokus efter amerikansk afvisning i ventet rødt marked
07:36 Per Aarsleff får hævet kursmål efter regnskab
07:25 Vægttab med Novos Cagrisema på 25 pct. eller mere kan give kursraket spår Nordnet